sellWeak10b5-1 plan
Peter Virsik sold $4,271 of EPIX
Chief Operating Officer at ESSA Pharma Inc.. 699 shares at an average of $6.11, traded Jan 5, 2024, filed Jan 8, 2024.
Warning score
0Value
$4,271
699 shares
Holdings after
14,022
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- 0Trade size$4k at market
- 0Share of holdings soldSold 4.7% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001209191-24-001198, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 5, 2024 | SOpen-market sale Common Shares10b5-1 | -699 | $6.11 | $4,271 | 14,022 | Jan 8, 2024 |
Related signals
Other insiders at ESSA Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | EPIXsell ESSA Pharma Inc. | Bvf Partners L P/il owner | $293 156 shares | -0% | |
| 57Moderate | EPIXsell ESSA Pharma Inc. | Biotech Growth N V owner | $12M 7,879,583 shares | -100% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,823 694 shares | -6% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $5,510 694 shares | -5% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $6,232 694 shares | -5% | |
| 26Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $749k 72,782 shares | -85% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $11k 1,194 shares | -9% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $17k 1,718 shares | -11% | |
| 28Weak | EPIXbuy ESSA Pharma Inc. | David Ross Parkinson Chief Executive Officer | $21k 9,223 shares | +16% | |
| 31Weak | EPIXbuy ESSA Pharma Inc. | Franklin M Berger director | $133k 23,259 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.